DPF1
Zinc finger protein neuro-d4
Also known as: BAF45b, DPF1_HUMAN, NEUD4, neuro-d4, SMARCG1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q92782
- Gene
- DPF1
- Ensembl
- ENSG00000011332
- Chromosome
- 19
- Canonical length
- 387 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Mitochondria,Cytosol
OverviewNCBI Gene
Enables sequence-specific double-stranded DNA binding activity. Predicted to be involved in nervous system development. Predicted to be located in chromatin and nucleoplasm. Predicted to be part of nBAF complex. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
387 residues, UniProt reviewed canonical sequence.
>Q92782|DPF1
1 MATVIPGPLS LGEDFYREAI EHCRSYNARL CAERSLRLPF LDSQTGVAQN NCYIWMEKTH
61 RGPGLAPGQI YTYPARCWRK KRRLNILEDP RLRPCEYKID CEAPLKKEGG LPEGPVLEAL
121 LCAETGEKKI ELKEEETIMD CQKQQLLEFP HDLEVEDLED DIPRRKNRAK GKAYGIGGLR
181 KRQDTASLED RDKPYVCDIC GKRYKNRPGL SYHYTHTHLA EEEGEENAER HALPFHRKNN
241 HKQFYKELAW VPEAQRKHTA KKAPDGTVIP NGYCDFCLGG SKKTGCPEDL ISCADCGRSG
301 HPSCLQFTVN MTAAVRTYRW QCIECKSCSL CGTSENDDQL LFCDDCDRGY HMYCLSPPMA
361 EPPEGSWSCH LCLRHLKEKA SAYITLTLocalizationUniProt · AlphaFold · HPA
Whether an antibody against DPF1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.52
- Highest tissue expression
- 31 nTPM
Expression across tissuesHPA
Tissue
- cerebral cortex: 31 nTPM
- basal ganglia: 22 nTPM
- hippocampal formation: 19 nTPM
- amygdala: 18 nTPM
- hypothalamus: 12 nTPM
- cerebellum: 9.6 nTPM
Single-cell type
- late spermatids: 48 nCPM
- early spermatids: 35 nCPM
- oligodendrocyte progenitor cells: 32 nCPM
- brain inhibitory neurons: 31 nCPM
- retinal amacrine cells: 30 nCPM
- retinal horizontal cells: 28 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- cerebral cortex: 50 nTPM
- hippocampal formation: 43 nTPM
- basal ganglia: 39 nTPM
- white matter: 38 nTPM
- amygdala: 30 nTPM
- hypothalamus: 28 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.28
- gnomAD pLI
- 0.99
- gnomAD missense Z
- 3.07
- DepMap mean gene effect
- -0.13
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- apoptotic process
- chromatin remodeling
- nervous system development
- positive regulation of cell differentiation
- positive regulation of double-strand break repair
- regulation of G0 to G1 transition
- regulation of G1/S transition of mitotic cell cycle
- regulation of mitotic metaphase/anaphase transition
- regulation of nucleotide-excision repair
- regulation of transcription by RNA polymerase II
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of DPF1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads DPF1 as an antibody target. Whether an autoantibody or antibody against DPF1 could matter depends on whether native DPF1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
DPF1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label DPF1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...